{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "31816012", "DateCompleted": {"Year": "2021", "Month": "08", "Day": "30"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "22"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1001/jamainternmed.2019.5498"], "Journal": {"ISSN": "2168-6114", "JournalIssue": {"Volume": "180", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Jan", "Day": "01"}}, "Title": "JAMA internal medicine", "ISOAbbreviation": "JAMA Intern Med"}, "ArticleTitle": "Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.", "Pagination": {"StartPage": "106", "EndPage": "115", "MedlinePgn": "106-115"}, "Abstract": {"AbstractText": ["Few studies have investigated the association of long-term ambient ozone exposures with respiratory morbidity among individuals with a heavy smoking history.", "To investigate the association of historical ozone exposure with risk of chronic obstructive pulmonary disease (COPD), computed tomography (CT) scan measures of respiratory disease, patient-reported outcomes, disease severity, and exacerbations in smokers with or at risk for COPD.", "This multicenter cross-sectional study, conducted from November 1, 2010, to July 31, 2018, obtained data from the Air Pollution Study, an ancillary study of SPIROMICS (Subpopulations and Intermediate Outcome Measures in COPD Study). Data analyzed were from participants enrolled at 7 (New York City, New York; Baltimore, Maryland; Los Angeles, California; Ann Arbor, Michigan; San Francisco, California; Salt Lake City, Utah; and Winston-Salem, North Carolina) of the 12 SPIROMICS clinical sites. Included participants had historical ozone exposure data (n\u2009=\u20091874), were either current or former smokers (\u226520 pack-years), were with or without COPD, and were aged 40 to 80 years at baseline. Healthy persons with a smoking history of 1 or more pack-years were excluded from the present analysis.", "The 10-year mean historical ambient ozone concentration at participants' residences estimated by cohort-specific spatiotemporal modeling.", "Spirometry-confirmed COPD, chronic bronchitis diagnosis, CT scan measures (emphysema, air trapping, and airway wall thickness), 6-minute walk test, modified Medical Research Council (mMRC) Dyspnea Scale, COPD Assessment Test (CAT), St. George's Respiratory Questionnaire (SGRQ), postbronchodilator forced expiratory volume in the first second of expiration (FEV1) % predicted, and self-report of exacerbations in the 12 months before SPIROMICS enrollment, adjusted for demographics, smoking, and job exposure.", "A total of 1874 SPIROMICS participants were analyzed (mean [SD] age, 64.5 [8.8] years; 1479 [78.9%] white; and 1013 [54.1%] male). In adjusted analysis, a 5-ppb (parts per billion) increase in ozone concentration was associated with a greater percentage of emphysema (\u03b2\u2009=\u20090.94; 95% CI, 0.25-1.64; P\u2009=\u2009.007) and percentage of air trapping (\u03b2\u2009=\u20091.60; 95% CI, 0.16-3.04; P\u2009=\u2009.03); worse scores for the mMRC Dyspnea Scale (\u03b2\u2009=\u20090.10; 95% CI, 0.03-0.17; P\u2009=\u2009.008), CAT (\u03b2\u2009=\u20090.65; 95% CI, 0.05-1.26; P\u2009=\u2009.04), and SGRQ (\u03b2\u2009=\u20091.47; 95% CI, 0.01-2.93; P\u2009=\u2009.048); lower FEV1% predicted value (\u03b2\u2009=\u2009-2.50; 95% CI, -4.42 to -0.59; P\u2009=\u2009.01); and higher odds of any exacerbation (odds ratio [OR],\u20091.37; 95% CI, 1.12-1.66; P\u2009=\u2009.002) and severe exacerbation (OR,\u20091.37; 95% CI, 1.07-1.76; P\u2009=\u2009.01). No association was found between historical ozone exposure and chronic bronchitis, COPD, airway wall thickness, or 6-minute walk test result.", "This study found that long-term historical ozone exposure was associated with reduced lung function, greater emphysema and air trapping on CT scan, worse patient-reported outcomes, and increased respiratory exacerbations for individuals with a history of heavy smoking. The association between ozone exposure and adverse respiratory outcomes suggests the need for continued reevaluation of ambient pollution standards that are designed to protect the most vulnerable members of the US population."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire."}, {"Identifier": [], "Affiliation": "Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire."}], "Identifier": [], "LastName": "Paulin", "ForeName": "Laura M", "Initials": "LM"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental and Occupational Health Sciences, University of Washington School of Public Health, Seattle."}], "Identifier": [], "LastName": "Gassett", "ForeName": "Amanda J", "Initials": "AJ"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill."}], "Identifier": [], "LastName": "Alexis", "ForeName": "Neil E", "Initials": "NE"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental and Occupational Health Sciences, University of Washington School of Public Health, Seattle."}], "Identifier": [], "LastName": "Kirwa", "ForeName": "Kipruto", "Initials": "K"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Utah, Salt Lake City."}], "Identifier": [], "LastName": "Kanner", "ForeName": "Richard E", "Initials": "RE"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Wake Forest University, Winston-Salem, North Carolina."}], "Identifier": [], "LastName": "Peters", "ForeName": "Stephen", "Initials": "S"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Illinois at Chicago, Chicago."}], "Identifier": [], "LastName": "Krishnan", "ForeName": "Jerry A", "Initials": "JA"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Utah, Salt Lake City."}], "Identifier": [], "LastName": "Paine", "ForeName": "Robert", "Initials": "R", "Suffix": "3rd"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Alabama, Birmingham."}], "Identifier": [], "LastName": "Dransfield", "ForeName": "Mark", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of California, San Francisco."}], "Identifier": [], "LastName": "Woodruff", "ForeName": "Prescott G", "Initials": "PG"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of California, Los Angeles."}], "Identifier": [], "LastName": "Cooper", "ForeName": "Christopher B", "Initials": "CB"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Columbia University Medical Center, New York, New York."}, {"Identifier": [], "Affiliation": "Department of Epidemiology, Columbia University Medical Center, New York, New York."}], "Identifier": [], "LastName": "Barr", "ForeName": "R Graham", "Initials": "RG"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Iowa, Iowa City."}], "Identifier": [], "LastName": "Comellas", "ForeName": "Alejandro P", "Initials": "AP"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Utah, Salt Lake City."}], "Identifier": [], "LastName": "Pirozzi", "ForeName": "Cheryl S", "Initials": "CS"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Michigan, Ann Arbor."}], "Identifier": [], "LastName": "Han", "ForeName": "MeiLan", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, University of Iowa, Iowa City."}], "Identifier": [], "LastName": "Hoffman", "ForeName": "Eric A", "Initials": "EA"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Weill Cornell Medicine, New York, New York."}], "Identifier": [], "LastName": "Martinez", "ForeName": "Fernando J", "Initials": "FJ"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Johns Hopkins University, Baltimore, Maryland."}], "Identifier": [], "LastName": "Woo", "ForeName": "Han", "Initials": "H"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."}], "Identifier": [], "LastName": "Peng", "ForeName": "Roger D", "Initials": "RD"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Johns Hopkins University, Baltimore, Maryland."}], "Identifier": [], "LastName": "Fawzy", "ForeName": "Ashraf", "Initials": "A"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Johns Hopkins University, Baltimore, Maryland."}], "Identifier": [], "LastName": "Putcha", "ForeName": "Nirupama", "Initials": "N"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Health Sciences and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."}, {"Identifier": [], "Affiliation": "National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, Georgia."}], "Identifier": [], "LastName": "Breysse", "ForeName": "Patrick N", "Initials": "PN"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental and Occupational Health Sciences, University of Washington School of Public Health, Seattle."}, {"Identifier": [], "Affiliation": "Department of Medicine, University of Washington, Seattle."}, {"Identifier": [], "Affiliation": "Department of Epidemiology, University of Washington, Seattle."}], "Identifier": [], "LastName": "Kaufman", "ForeName": "Joel D", "Initials": "JD"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Johns Hopkins University, Baltimore, Maryland."}], "Identifier": [], "LastName": "Hansel", "ForeName": "Nadia N", "Initials": "NN"}, {"AffiliationInfo": [], "Identifier": [], "CollectiveName": "for SPIROMICS investigators"}], "GrantList": [{"GrantID": "HHSN268200900019C", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HHSN268200900016C", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES005605", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "HHSN268200900015C", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "U01 HL137880", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HHSN268200900013C", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "S10 OD018526", "Acronym": "OD", "Agency": "NIH HHS", "Country": "United States"}, {"GrantID": "K23 ES025781", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "HHSN268200900014C", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES023500", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "K24 HL137013", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HHSN268200900020C", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HHSN268200900017C", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HHSN268200900018C", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES007033", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Multicenter Study", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "JAMA Intern Med", "NlmUniqueID": "101589534", "ISSNLinking": "2168-6106"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "CommentsCorrectionsList": [{"RefSource": "JAMA Intern Med. 2020 Jan 1;180(1):115-116. doi: 10.1001/jamainternmed.2019.5967", "PMID": "31816008"}, {"RefSource": "JAMA Intern Med. 2020 May 1;180(5):804. doi: 10.1001/jamainternmed.2020.0577", "PMID": "32227129"}, {"RefSource": "JAMA Intern Med. 2020 May 1;180(5):803-804. doi: 10.1001/jamainternmed.2020.0574", "PMID": "32227130"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Air Pollution"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": [], "DescriptorName": "Forced Expiratory Volume"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Morbidity"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["diagnosis", "epidemiology", "physiopathology"], "DescriptorName": "Pulmonary Emphysema"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}, {"QualifierName": ["methods"], "DescriptorName": "Risk Assessment"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Smoking"}, {"QualifierName": [], "DescriptorName": "Tomography, X-Ray Computed"}, {"QualifierName": ["epidemiology"], "DescriptorName": "United States"}], "CoiStatement": "<b>Conflict of Interest Disclosures:</b> Dr Paulin reported receiving grants from National Institute of Environmental Health Sciences (NIEHS) during the conduct of the study. Dr Gassett reported receiving grants from the National Institutes of Health (NIH) and the US Environmental Protection Agency (EPA) during the conduct of the study. Dr Kanner reported receiving a grant from the National Heart, Lung, and Blood Institute (NHLBI) during the conduct of the study. Dr Peters reported receiving grants from the NIH/NHLBI during the conduct of the study. Dr Krishnan reported receiving grants from the NIH/NHLBI during the conduct of the study. Dr Paine reported receiving grants from the NHLBI and the COPD Foundation during the conduct of the study as well as grants from the Department of Veterans Affairs outside the submitted work. Dr Dransfield reported receiving grants from the NIH during the conduct of the study; grants from the Department of Defense, American Lung Association, and Department of Veterans Affairs; and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mereo, Pulmonx, PneumRx/BTG, and Quark outside the submitted work. Dr Woodruff reported receiving grants from the NIH/NHLBI and COPD Foundation during the conduct of the study as well as personal fees from Glenmark Pharmaceuticals, Theravance, GlaxoSmithKline, NGM Pharmaceuticals, Amgen, Genentech, Regeneron, Sanofi, AstraZeneca, and 23andMe outside the submitted work. Dr Cooper reported receiving personal fees from GlaxoSmithKline outside the submitted work. Dr Barr reported receiving grants from the NIH and COPD Foundation during the conduct of the study. Dr Comellas reported receiving grants from the NIH/NHLBI, NIH/NIEHS, and NIH/National Center for Advancing Translational Sciences during the conduct of the study; personal fees from GlaxoSmithKline; and nonfinancial support from VIDA Diagnostics outside the submitted work. Dr Han reported receiving personal fees from GlaxoSmithKline, Boehringer Ingelheim, Mylan, and AstraZeneca as well as nonfinancial support from Novartis and Sunovion outside the submitted work. Dr Hoffman reported being a founder and shareholder of VIDA Diagnostics, a company commercializing lung image analysis software that was developed in part at the University of Iowa. Dr Martinez reported receiving grants from the NHLBI during the conduct of the study. Dr Peng reported receiving grants from the NIH and the EPA during the conduct of the study and personal fees from Health Effects Institute outside the submitted work. Dr Putcha reported receiving grants from the NHLBI during the conduct of the study. Dr Kaufman reported receiving grants from the NIH and the EPA during the conduct of the study. Dr Hansel reported receiving grants and personal fees from AstraZeneca and GlaxoSmithKline; grants from Boehringer Ingelheim, the NIH, and COPD Foundation; and personal fees from Mylan outside the submitted work. No other disclosures were reported."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "US Environmental Protection Agency . Integrated Science Assessment (ISA) of Ozone and Related Photochemical Oxidants. Final Report. Washington, DC: US Environmental Protection Agency; 2013."}, {"Citation": "Mortimer KM, Neas LM, Dockery DW, Redline S, Tager IB. The effect of air pollution on inner-city children with asthma. Eur Respir J. 2002;19(4):699-705. doi:10.1183/09031936.02.00247102", "ArticleIdList": ["10.1183/09031936.02.00247102", "11999000"]}, {"Citation": "Chan CC, Wu TH. Effects of ambient ozone exposure on mail carriers\u2019 peak expiratory flow rates. Environ Health Perspect. 2005;113(6):735-738. doi:10.1289/ehp.7636", "ArticleIdList": ["10.1289/ehp.7636", "PMC1257599", "15929897"]}, {"Citation": "Tolbert PE, Klein M, Peel JL, Sarnat SE, Sarnat JA. Multipollutant modeling issues in a study of ambient air quality and emergency department visits in Atlanta. J Expo Sci Environ Epidemiol. 2007;17(suppl 2):S29-S35. doi:10.1038/sj.jes.7500625", "ArticleIdList": ["10.1038/sj.jes.7500625", "18079762"]}, {"Citation": "Jerrett M, Burnett RT, Pope CA III, et al. . Long-term ozone exposure and mortality. N Engl J Med. 2009;360(11):1085-1095. doi:10.1056/NEJMoa0803894", "ArticleIdList": ["10.1056/NEJMoa0803894", "PMC4105969", "19279340"]}, {"Citation": "Turner MC, Jerrett M, Pope CA III, et al. . Long-term ozone exposure and mortality in a large prospective study. Am J Respir Crit Care Med. 2016;193(10):1134-1142. doi:10.1164/rccm.201508-1633OC", "ArticleIdList": ["10.1164/rccm.201508-1633OC", "PMC4872664", "26680605"]}, {"Citation": "Zanobetti A, Schwartz J. Ozone and survival in four cohorts with potentially predisposing diseases. Am J Respir Crit Care Med. 2011;184(7):836-841. doi:10.1164/rccm.201102-0227OC", "ArticleIdList": ["10.1164/rccm.201102-0227OC", "PMC3208652", "21700916"]}, {"Citation": "Lim CC, Hayes RB, Ahn J, et al. . Long-term exposure to ozone and cause-specific mortality risk in the U.S [published online May 3, 2019]. Am J Respir Crit Care Med.", "ArticleIdList": ["PMC6794108", "31051079"]}, {"Citation": "Wang M, Aaron CP, Madrigano J, et al. . Association between long-term exposure to ambient air pollution and change in quantitatively assessed emphysema and lung function. JAMA. 2019;322(6):546-556. doi:10.1001/jama.2019.10255", "ArticleIdList": ["10.1001/jama.2019.10255", "PMC6692674", "31408135"]}, {"Citation": "Woodruff PG, Barr RG, Bleecker E, et al. ; SPIROMICS Research Group . Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811-1821. doi:10.1056/NEJMoa1505971", "ArticleIdList": ["10.1056/NEJMoa1505971", "PMC4968204", "27168432"]}, {"Citation": "Regan EA, Lynch DA, Curran-Everett D, et al. ; Genetic Epidemiology of COPD (COPDGene) Investigators . Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175(9):1539-1549. doi:10.1001/jamainternmed.2015.2735", "ArticleIdList": ["10.1001/jamainternmed.2015.2735", "PMC4564354", "26098755"]}, {"Citation": "World Health Organization . Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: World Health Organization; 2011."}, {"Citation": "Couper D, LaVange LM, Han M, et al. ; SPIROMICS Research Group . Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax. 2014;69(5):491-494. doi:10.1136/thoraxjnl-2013-203897", "ArticleIdList": ["10.1136/thoraxjnl-2013-203897", "PMC3954445", "24029743"]}, {"Citation": "Hansel NN, Paulin LM, Gassett AJ, et al. . Design of the subpopulations and intermediate outcome measures in COPD (SPIROMICS) AIR study. BMJ Open Respir Res. 2017;4(1):e000186. doi:10.1136/bmjresp-2017-000186", "ArticleIdList": ["10.1136/bmjresp-2017-000186", "PMC5595208", "28948026"]}, {"Citation": "Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179-187. doi:10.1164/ajrccm.159.1.9712108", "ArticleIdList": ["10.1164/ajrccm.159.1.9712108", "9872837"]}, {"Citation": "Sampson PD, Szpiro AA, Sheppard L, Lindstr\u00f6m J, Kaufman JD. Pragmatic estimation of a spatio-temporal air quality model with irregular monitoring data. Atmos Environ. 2011;45(36):6593-6606. doi:10.1016/j.atmosenv.2011.04.073", "ArticleIdList": ["10.1016/j.atmosenv.2011.04.073"]}, {"Citation": "Wang M, Keller JP, Adar SD, et al. . Development of long-term spatiotemporal models for ambient ozone in six metropolitan regions of the United States: the MESA Air study. Atmos Environ (1994). 2015;123(A):79-87. doi:10.1016/j.atmosenv.2015.10.042", "ArticleIdList": ["10.1016/j.atmosenv.2015.10.042", "PMC5021184", "27642250"]}, {"Citation": "Spalt EW, Curl CL, Allen RW, et al. . Time-location patterns of a diverse population of older adults: the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air). J Expo Sci Environ Epidemiol. 2016;26(4):349-355. doi:10.1038/jes.2015.29", "ArticleIdList": ["10.1038/jes.2015.29", "PMC4641054", "25921083"]}, {"Citation": "Matte TD, Ross Z, Kheirbek I, et al. . Monitoring intraurban spatial patterns of multiple combustion air pollutants in New York City: design and implementation. J Expo Sci Environ Epidemiol. 2013;23(3):223-231. doi:10.1038/jes.2012.126", "ArticleIdList": ["10.1038/jes.2012.126", "23321861"]}, {"Citation": "Blanc PD, Eisner MD, Balmes JR, Trupin L, Yelin EH, Katz PP. Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. Am J Ind Med. 2005;48(2):110-117. doi:10.1002/ajim.20187", "ArticleIdList": ["10.1002/ajim.20187", "PMC2648972", "16032739"]}, {"Citation": "Mehta AJ, Miedinger D, Keidel D, et al. ; SAPALDIA Team . Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults. Am J Respir Crit Care Med. 2012;185(12):1292-1300. doi:10.1164/rccm.201110-1917OC", "ArticleIdList": ["10.1164/rccm.201110-1917OC", "22492989"]}, {"Citation": "Sadhra S, Kurmi OP, Sadhra SS, Lam KB, Ayres JG. Occupational COPD and job exposure matrices: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2017;12:725-734. doi:10.2147/COPD.S125980", "ArticleIdList": ["10.2147/COPD.S125980", "PMC5327910", "28260879"]}, {"Citation": "US Census Bureau . American community survey. US Department of Commerce, Economics and Statistics Administration. https://www.census.gov/programs-surveys/acs/. Accessed January 10, 2019."}, {"Citation": "Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George\u2019s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321-1327. doi:10.1164/ajrccm/145.6.1321", "ArticleIdList": ["10.1164/ajrccm/145.6.1321", "1595997"]}, {"Citation": "Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-654. doi:10.1183/09031936.00102509", "ArticleIdList": ["10.1183/09031936.00102509", "19720809"]}, {"Citation": "Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586. doi:10.1136/thx.54.7.581", "ArticleIdList": ["10.1136/thx.54.7.581", "PMC1745516", "10377201"]}, {"Citation": "Holland AE, Spruit MA, Troosters T, et al. . An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-1446. doi:10.1183/09031936.00150314", "ArticleIdList": ["10.1183/09031936.00150314", "25359355"]}, {"Citation": "Kim V, Crapo J, Zhao H, et al. ; COPDGene Investigators . Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc. 2015;12(3):332-339. doi:10.1513/AnnalsATS.201411-518OC", "ArticleIdList": ["10.1513/AnnalsATS.201411-518OC", "PMC4418311", "25575351"]}, {"Citation": "Sieren JP, Newell JD Jr, Barr RG, et al. ; SPIROMICS Research Group . SPIROMICS protocol for multicenter quantitative computed tomography to phenotype the lungs. Am J Respir Crit Care Med. 2016;194(7):794-806. doi:10.1164/rccm.201506-1208PP", "ArticleIdList": ["10.1164/rccm.201506-1208PP", "PMC5074650", "27482984"]}, {"Citation": "Kim WJ, Silverman EK, Hoffman E, et al. ; NETT Research Group . CT metrics of airway disease and emphysema in severe COPD. Chest. 2009;136(2):396-404. doi:10.1378/chest.08-2858", "ArticleIdList": ["10.1378/chest.08-2858", "PMC2733947", "19411295"]}, {"Citation": "Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. J R Stat Soc Ser C Appl Stat. 1994;43(3):429-453. doi:10.2307/2986270", "ArticleIdList": ["10.2307/2986270"]}, {"Citation": "Heron M. Deaths: leading causes for 2016. Natl Vital Stat Rep. 2018;67(6):1-77.", "ArticleIdList": ["30248017"]}, {"Citation": "Wood AM, Harrison RM, Semple S, Ayres JG, Stockley RA. Outdoor air pollution is associated with disease severity in \u03b11-antitrypsin deficiency. Eur Respir J. 2009;34(2):346-353. doi:10.1183/09031936.00087908", "ArticleIdList": ["10.1183/09031936.00087908", "19324958"]}, {"Citation": "Paulin LM, Smith BM, Koch A, et al. . Occupational exposures and computed tomographic imaging characteristics in the SPIROMICS Cohort. Ann Am Thorac Soc. 2018;15(12):1411-1419. doi:10.1513/AnnalsATS.201802-150OC", "ArticleIdList": ["10.1513/AnnalsATS.201802-150OC", "PMC6322018", "30339479"]}, {"Citation": "Chen CH, Chan CC, Chen BY, Cheng TJ, Leon Guo Y. Effects of particulate air pollution and ozone on lung function in non-asthmatic children. Environ Res. 2015;137:40-48. doi:10.1016/j.envres.2014.11.021", "ArticleIdList": ["10.1016/j.envres.2014.11.021", "25486544"]}, {"Citation": "Meng Y-Y, Rull RP, Wilhelm M, Lombardi C, Balmes J, Ritz B. Outdoor air pollution and uncontrolled asthma in the San Joaquin Valley, California. J Epidemiol Community Health. 2010;64(2):142-147. doi:10.1136/jech.2009.083576", "ArticleIdList": ["10.1136/jech.2009.083576", "20056967"]}, {"Citation": "Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012;9(2):131-141. doi:10.3109/15412555.2011.650239", "ArticleIdList": ["10.3109/15412555.2011.650239", "22409371"]}, {"Citation": "Global Initiative for Chronic Obstructive Lung Disease . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2019 Report. https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed March 23, 2019."}, {"Citation": "Centers for Disease Control and Prevention . National hospital ambulatory medical care survey: 2015 emergency department summary tables. https://www.cdc.gov/nchs/data/nhamcs/web_tables/2015_ed_web_tables.pdf. Accessed April 18, 2019"}, {"Citation": "Soler-Catalu\u00f1a JJ, Mart\u00ednez-Garc\u00eda M\u00c1, Rom\u00e1n S\u00e1nchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925-931. doi:10.1136/thx.2005.040527", "ArticleIdList": ["10.1136/thx.2005.040527", "PMC1747235", "16055622"]}, {"Citation": "Geyh AS, Xue J, Ozkaynak H, Spengler JD. The Harvard Southern California Chronic Ozone Exposure Study: assessing ozone exposure of grade-school-age children in two Southern California communities. Environ Health Perspect. 2000;108(3):265-270. doi:10.1289/ehp.00108265", "ArticleIdList": ["10.1289/ehp.00108265", "PMC1637960", "10706534"]}, {"Citation": "Hansel NN, McCormack MC, Belli AJ, et al. . In-home air pollution is linked to respiratory morbidity in former smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(10):1085-1090. doi:10.1164/rccm.201211-1987OC", "ArticleIdList": ["10.1164/rccm.201211-1987OC", "PMC3734614", "23525930"]}, {"Citation": "Paulin LM, Diette GB, Blanc PD, et al. ; SPIROMICS Research Group . Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(5):557-565. doi:10.1164/rccm.201408-1407OC", "ArticleIdList": ["10.1164/rccm.201408-1407OC", "PMC4384767", "25562375"]}, {"Citation": "Guo C, Zhang Z, Lau AKH, et al. . Effect of long-term exposure to fine particulate matter on lung function decline and risk of chronic obstructive pulmonary disease in Taiwan: a longitudinal, cohort study. Lancet Planet Health. 2018;2(3):e114-e125. doi:10.1016/S2542-5196(18)30028-7", "ArticleIdList": ["10.1016/S2542-5196(18)30028-7", "29615226"]}, {"Citation": "Hansel NN, McCormack MC, Kim V. The effects of air pollution and temperature on COPD. COPD. 2016;13(3):372-379. doi:10.3109/15412555.2015.1089846", "ArticleIdList": ["10.3109/15412555.2015.1089846", "PMC4878829", "26683097"]}, {"Citation": "The Lancet . Air pollution: a major threat to lung health. Lancet. 2019;393(10183):1774. doi:10.1016/S0140-6736(19)30992-4", "ArticleIdList": ["10.1016/S0140-6736(19)30992-4", "31057148"]}, {"Citation": "Alexis NE, Lay JC, Zhou H, et al. . The glutathione-S-transferase mu 1 (GSTM1) null genotype and increased neutrophil response to low-level ozone (0.06 ppm). J Allergy Clin Immunol. 2013;131(2):610-612. doi:10.1016/j.jaci.2012.07.005", "ArticleIdList": ["10.1016/j.jaci.2012.07.005", "PMC3509264", "22921799"]}, {"Citation": "American Lung Association . The State of the Air. 2019. https://www.lung.org/about-us/media/top-stories/state-of-the-air-2019.html. Accessed July 17, 2019."}, {"Citation": "US Environmental Protection Agency. National air quality: status and trends of key air pollutants. https://www.epa.gov/air-trends. Accessed August 29, 2019."}, {"Citation": "Balmes JR. Long-term exposure to ozone and cardiopulmonary mortality: epidemiology strikes again [published June 11, 2019]. Am J Respir Crit Care Med. doi:10.1164/rccm.201906-1105ED", "ArticleIdList": ["10.1164/rccm.201906-1105ED", "PMC6794103", "31185178"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31816012", "PMC6902160", "10.1001/jamainternmed.2019.5498", "2757312"]}}]}